# An integrated map of genetic variation from 1,092 human genomes.

- **DOI:** [10.1038/nature11632](https://doi.org/10.1038/nature11632)
- **Rating:** Exemplary (4.5 out of 5)
- **Verdict:** A landmark resource paper that delivers transformative scale and rigorous validation, with population coverage as its principal constraint.
- **Framework version:** v5.0
- **Pipeline version:** v0.3
- **Evaluation date:** 2026-05-18
- **Evaluation page:** https://www.nabu.science/paper/10.1038%2Fnature11632

## Strengths

- **Rigorous FDR validation with transparent limitation reporting** Validation using frequency-matched external data across all variant types, with honest disclosure of the initial high indel FDR (27/76 = 35.5%) and the subsequent application of additional filters reducing it to 5.4%. This level of self-critical transparency strengthens confidence in the resource quality.
  - Dimension: methodological rigour
  - Location: Table S6; Supplementary Information; main text validation paragraphs
- **Comprehensive rare-variant characterization advancing the field** The resource fills a documented gap: only 13% of variants below 0.5% frequency and 62% of variants in the 0.5-5% range had been previously described. The resource enables analysis at frequency strata that were inaccessible with prior tools, with 99.3% power to detect SNPs at 1% frequency.
  - Dimension: contribution
  - Location: Abstract; Distribution of variation section; UK10K comparison
- **Immediate operational utility with quantified performance** The resource was already in active use for exome variant screening and GWAS imputation at publication. Imputation accuracy of 90-95% for common variants in non-African populations is documented and comparable to high-quality benchmark haplotypes, with a 25% increase over the Pilot Phase and >2-fold over HapMap.
  - Dimension: application pathway
  - Location: Uses of 1000 Genomes Project Data in Medical Genetics; Figs. 5a, S14a-c

## Limitations

- **Methods detail deferred to supplementary materials** The Methods Summary states only that 'All details concerning sample collection, data generation, processing and analysis can be found in the Supplementary Information.' This limits independent assessment of analytical choices from the main paper alone, though this was standard practice for Nature papers of this era.
  - Dimension: methodological rigour
  - Location: Methods Summary
- **Limited coverage for underrepresented populations** Coverage drops substantially for populations not closely related to those studied. For example, the resource includes only 76.9% of SNPs at 1% frequency in the isolated Sardinian population, compared to 98% in UK-sampled genomes. This limits the resource's utility for population-specific analyses in underrepresented groups.
  - Dimension: application pathway
  - Location: SardiNIA comparison paragraph; Discussion
- **Ethics and COI documentation not visible in main text** Ethics approval for sample collection and conflict of interest disclosures are not explicitly stated in the available main text. While this documentation would typically appear in supplementary materials for a large consortium paper of this era, its absence from the main text limits verification of research conduct standards.
  - Dimension: methodological rigour
  - Location: Methods Summary

## Reliability checks

Caveats (3 of 4 checks).

- **Internal coherence:** Clean. The paper is internally consistent across abstract, main text, tables, and figures. Key quantitative claims (38 million SNPs, 1.4 million indels, 14,000 large deletions) are stated consistently throughout, and the FDR estimates are reported with appropriate nuance including honest disclosure of the initial high indel FDR.
- **Research conduct:** Noted. Data availability is clearly claimed and the resource was publicly available via the 1000genomes.org website. However, ethics approval and COI disclosure are not explicitly stated in the available text, and data hosting is via project websites rather than a persistent repository with formal identifiers.
- **Reference integrity:** Pending

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
